Compare SIDU & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIDU | PRPO |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.4M | 42.0M |
| IPO Year | 2021 | 2000 |
| Metric | SIDU | PRPO |
|---|---|---|
| Price | $2.33 | $28.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 104.8K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 66.94 | ★ 92.15 |
| EPS | ★ N/A | N/A |
| Revenue | $3,383,878.00 | ★ $24,049,000.00 |
| Revenue This Year | $171.29 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 29.77 |
| 52 Week Low | $0.63 | $14.04 |
| 52 Week High | $6.79 | $33.63 |
| Indicator | SIDU | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 73.32 |
| Support Level | $1.73 | $22.25 |
| Resistance Level | $2.67 | $29.02 |
| Average True Range (ATR) | 0.22 | 1.81 |
| MACD | 0.06 | 0.66 |
| Stochastic Oscillator | 63.02 | 97.56 |
Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.